{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T23:29:36Z","timestamp":1774308576375,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T00:00:00Z","timestamp":1570406400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T00:00:00Z","timestamp":1570406400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Perinatol"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1038\/s41372-019-0518-3","type":"journal-article","created":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T08:03:00Z","timestamp":1570435380000},"page":"1439-1441","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Pharmacological closure of the patent ductus arteriosus: when treatment still makes sense"],"prefix":"10.1038","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3552-9196","authenticated-orcid":false,"given":"Maria","family":"Gillam-Krakauer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James I.","family":"Hagadorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeff","family":"Reese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,7]]},"reference":[{"key":"518_CR1","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1056\/NEJM200106283442602","volume":"344","author":"B Schmidt","year":"2001","unstructured":"Schmidt B, Davis P, Moddemann D, Ohlsson A, Roberts RS, Saigal S, et al. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med. 2001;344:1966\u201372.","journal-title":"N Engl J Med"},{"issue":"4","key":"518_CR2","doi-asserted-by":"publisher","first-page":"e20162390","DOI":"10.1542\/peds.2016-2390","volume":"139","author":"Samantha Ngo","year":"2017","unstructured":"Ngo S, Profit J, Gould JB, Lee HC. Trends in patent ductus arteriosus diagnosis and management for very low birth weight infants. Pediatrics. 2017;139:e20162390.","journal-title":"Pediatrics"},{"key":"518_CR3","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jpeds.2017.05.024","volume":"189","author":"GM Bixler","year":"2017","unstructured":"Bixler GM, Powers GC, Clark RH, Walker MW, Tolia VN. Changes in the diagnosis and management of patent ductus arteriosus from 2006 to 2015 in United States neonatal intensive care units. J Pediatr. 2017;189:105\u201312.","journal-title":"J Pediatr"},{"key":"518_CR4","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/pr.2016.166","volume":"80","author":"JI Hagadorn","year":"2016","unstructured":"Hagadorn JI, Brownell EA, Trzaski JM, Johnson KR, Lainwala S, Campbell BT, et al. Trends and variation in management and outcomes of very low-birth-weight infants with patent ductus arteriosus. Pediatr Res. 2016;80:785\u201392.","journal-title":"Pediatr Res"},{"key":"518_CR5","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1055\/s-0036-1593351","volume":"34","author":"A Lokku","year":"2017","unstructured":"Lokku A, Mirea L, Lee SK, Shah PS, Canadian Neonatal N. Trends and outcomes of patent ductus arteriosus treatment in very preterm infants in Canada. Am J Perinatol. 2017;34:441\u201350.","journal-title":"Am J Perinatol"},{"key":"518_CR6","doi-asserted-by":"publisher","first-page":"e164354","DOI":"10.1001\/jamapediatrics.2016.4354","volume":"171","author":"JL Slaughter","year":"2017","unstructured":"Slaughter JL, Reagan PB, Newman TB, Klebanoff MA. Comparative effectiveness of nonsteroidal anti-inflammatory drug treatment vs no treatment for patent ductus arteriosus in preterm infants. JAMA Pediatr. 2017;171:e164354.","journal-title":"JAMA Pediatr"},{"key":"518_CR7","doi-asserted-by":"publisher","first-page":"e0212256","DOI":"10.1371\/journal.pone.0212256","volume":"14","author":"SI Sung","year":"2019","unstructured":"Sung SI, Chang YS, Kim J, Choi JH, Ahn SY, Park WS. Natural evolution of ductus arteriosus with noninterventional conservative management in extremely preterm infants born at 23-28 weeks of gestation. PLoS One. 2019;14:e0212256.","journal-title":"PLoS One"},{"key":"518_CR8","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/jp.2017.4","volume":"37","author":"MA Mohamed","year":"2017","unstructured":"Mohamed MA, El-Dib M, Alqahtani S, Alyami K, Ibrahim AN, Aly H. Patent ductus arteriosus in premature infants: to treat or not to treat? J Perinatol. 2017;37:652\u20137.","journal-title":"J Perinatol"},{"key":"518_CR9","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1016\/j.jpeds.2015.03.012","volume":"166","author":"F Schena","year":"2015","unstructured":"Schena F, Francescato G, Cappelleri A, Picciolli I, Mayer A, Mosca F, et al. Association between Hemodynamically significant patent ductus arteriosus and bronchopulmonary dysplasia. J Pediatr. 2015;166:1488\u201392.","journal-title":"J Pediatr"},{"key":"518_CR10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12887-015-0480-y","volume":"15","author":"HL Chen","year":"2015","unstructured":"Chen HL, Yang RC, Lee WT, Lee PL, Hsu JH, Wu JR, et al. Lung function in very preterm infants with patent ductus arteriosus under conservative management: an observational study. BMC Pediatr. 2015;15:167.","journal-title":"BMC Pediatr"},{"key":"518_CR11","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1053\/j.semperi.2018.05.005","volume":"42","author":"EA Jensen","year":"2018","unstructured":"Jensen EA, Foglia EE, Schmidt B. Association between prophylactic indomethacin and death or bronchopulmonary dysplasia: a systematic review and meta-analysis of observational studies. Semin Perinatol. 2018;42:228\u201334.","journal-title":"Semin Perinatol"},{"key":"518_CR12","first-page":"5","volume":"3","author":"JWH Kaempf","year":"2013","unstructured":"Kaempf JWH, Wu R, Kaempf YX, Wang AJ, Grunkemeier L, MIschel G, et al. Permissive tolerance of the patent ductus arteriosus may increase the risk of chronic lung disease. Res Rep Neonatol. 2013;3:5\u201310.","journal-title":"Res Rep Neonatol"},{"key":"518_CR13","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.jped.2014.04.010","volume":"90","author":"LS Sadeck","year":"2014","unstructured":"Sadeck LS, Leone CR, Procianoy RS, Guinsburg R, Marba ST, Martinez FE, et al. Effects of therapeutic approach on the neonatal evolution of very low birth weight infants with patent ductus arteriosus. J Pediatr. 2014;90:616\u201323.","journal-title":"J Pediatr"},{"key":"518_CR14","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jpeds.2018.07.025","volume":"203","author":"JI Hagadorn","year":"2018","unstructured":"Hagadorn JI, Bennett MV, Brownell EA, Payton KSE, Benitz WE, Lee HC. Covariation of Neonatal intensive care unit-level patent ductus arteriosus management and in-neonatal intensive care unit outcomes following preterm birth. J Pediatr. 2018;203:225\u201333 e221.","journal-title":"J Pediatr"},{"key":"518_CR15","first-page":"CD010061","volume":"4","author":"A Ohlsson","year":"2018","unstructured":"Ohlsson A, Shah PS. Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants. Cochrane Database Syst Rev. 2018;4:CD010061.","journal-title":"Cochrane Database Syst Rev"},{"key":"518_CR16","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41372-019-0347-4","volume":"39","author":"M Liebowitz","year":"2019","unstructured":"Liebowitz M, Kaempf J, Erdeve O, Bulbul A, Hakansson S, Lindqvist J, et al. Comparative effectiveness of drugs used to constrict the patent ductus arteriosus: a secondary analysis of the PDA-TOLERATE trial (NCT01958320). J Perinatol. 2019;39:599\u2013607.","journal-title":"J Perinatol"},{"key":"518_CR17","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.earlhumdev.2019.06.002","volume":"135","author":"C Dani","year":"2019","unstructured":"Dani C, Mosca F, Cresi F, Lago P, Lista G, Laforgia N, et al. Patent ductus arteriosus in preterm infants born at 23-24 weeks\u2019 gestation: Should we pay more attention? Early Hum Dev. 2019;135:16\u201322.","journal-title":"Early Hum Dev"},{"key":"518_CR18","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.jpeds.2006.01.047","volume":"148","author":"B Schmidt","year":"2006","unstructured":"Schmidt B, Roberts RS, Fanaroff A, Davis P, Kirpalani HM, Nwaesei C, et al. Indomethacin prophylaxis, patent ductus arteriosus, and the risk of bronchopulmonary dysplasia: further analyses from the trial of indomethacin prophylaxis in preterms (TIPP). J Pediatr. 2006;148:730\u20134.","journal-title":"J Pediatr"},{"key":"518_CR19","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jpeds.2017.03.021","volume":"187","author":"M Liebowitz","year":"2017","unstructured":"Liebowitz M, Clyman RI. Prophylactic indomethacin compared with delayed conservative management of the patent ductus arteriosus in extremely preterm infants: effects on neonatal outcomes. J Pediatr. 2017;187:119\u201326 e111.","journal-title":"J Pediatr"},{"key":"518_CR20","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jpeds.2017.02.003","volume":"186","author":"EA Jensen","year":"2017","unstructured":"Jensen EA, Dysart KC, Gantz MG, Carper B, Higgins RD, Keszler M, et al. Association between use of prophylactic indomethacin and the risk for bronchopulmonary dysplasia in extremely preterm infants. J Pediatr. 2017;186:34\u201340.e32.","journal-title":"J Pediatr"},{"key":"518_CR21","doi-asserted-by":"publisher","first-page":"222-226.e2","DOI":"10.1016\/j.jpeds.2019.05.049","volume":"213","author":"Melissa Liebowitz","year":"2019","unstructured":"Liebowitz M, Katheria A, Sauberan J, Singh J, Nelson K, Hassinger DC, et al. Lack of equipoise in the PDA-TOLERATE trial: a comparison of eligible infants enrolled in the trial and those treated outside the trial. J Pediatr. 2019;213:222\u2013226.e2.","journal-title":"The Journal of Pediatrics"},{"key":"518_CR22","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1053\/j.semperi.2011.09.022","volume":"36","author":"RI Clyman","year":"2012","unstructured":"Clyman RI, Couto J, Murphy GM. Patent ductus arteriosus: are current neonatal treatment options better or worse than no treatment at all? Semin Perinatol. 2012;36:123\u20139.","journal-title":"Semin Perinatol"},{"key":"518_CR23","doi-asserted-by":"publisher","first-page":"F99","DOI":"10.1136\/archdischild-2013-304695","volume":"99","author":"M Kluckow","year":"2014","unstructured":"Kluckow M, Jeffery M, Gill A, Evans N. A randomised placebo-controlled trial of early treatment of the patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed. 2014;99:F99\u2013104.","journal-title":"Arch Dis Child Fetal Neonatal Ed"}],"container-title":["Journal of Perinatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41372-019-0518-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41372-019-0518-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41372-019-0518-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:29:36Z","timestamp":1684618176000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41372-019-0518-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,7]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["518"],"URL":"https:\/\/doi.org\/10.1038\/s41372-019-0518-3","relation":{},"ISSN":["0743-8346","1476-5543"],"issn-type":[{"value":"0743-8346","type":"print"},{"value":"1476-5543","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,7]]},"assertion":[{"value":"11 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}